This statistic depicts the estimated avoidable healthcare costs due to delayed evidence-based treatment practice in the United States in 2012, by disease. In that year, atrial fibrillation was estimated to create a total of 0.7 billion U.S. dollars in avoidable costs. Total avoidable delayed evidence-based treatment practice healthcare costs reached 39.5 billion U.S. dollars in that year. Expected increase in insurance coverage, chronic diseases, and an aging population may place further stresses on the need for proper medication use to prevent avoidable healthcare costs.
Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
IMS Health. (June 28, 2013). Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* [Graph]. In Statista. Retrieved November 23, 2024, from https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. "Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*." Chart. June 28, 2013. Statista. Accessed November 23, 2024. https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. (2013). Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: November 23, 2024. https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health. "Avoidable Healthcare Costs Due to Delayed Treatment Practice in The U.S. in 2012, by Disease (in Billion U.S. Dollars)*." Statista, Statista Inc., 28 Jun 2013, https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
IMS Health, Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/ (last visited November 23, 2024)
Avoidable healthcare costs due to delayed treatment practice in the U.S. in 2012, by disease (in billion U.S. dollars)* [Graph], IMS Health, June 28, 2013. [Online]. Available: https://www.statista.com/statistics/320335/delayed-evidence-based-us-treatment-practice-healthcare-costs-by-disease/
